Literature DB >> 22489339

Obstetric perineal wound infection: is there underreporting?

Adeyemi Johnson1, Ranee Thakar, Abdul H Sultan.   

Abstract

UNLABELLED: Obstetric perineal wound infection is a complication of perineal trauma during vaginal delivery; however, it is difficult to establish its true incidence as women present for treatment to their GP or the hospital. AIM: To establish the incidence and risk factors of wound infection in postpartum women with sutured tears.
METHOD: A 3-month prospective audit was carried out on all women who sustained sutured tears. Wound infection was defined as the presence of any two of the following markers: perineal pain, wound dehiscence, or purulent vaginal discharge. A total of 341 women were contacted by telephone 21 days post-delivery and asked about markers for perineal wound infection and antibiotic use.
RESULTS: In total, 409 women sustained sutured perineal tears, including episiotomies, and first, second, third and fourth degree tears. Of the 341 (83%) women contacted, 39 (11%) had a perineal wound infection based on the criteria of any two infection markers. Sixteen(5%) women had all three markers of wound infection. Prolonged rupture of membranes and instrumental delivery was a significant risk factor for women with two and three markers of wound infection,respectively.
CONCLUSION: One in ten women who sustained a perineal tear at vaginal delivery that required suturing developed perineal wound infection. Instrumental deliveries and prolonged rupture of membranes predispose women to perineal wound infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22489339     DOI: 10.12968/bjon.2012.21.Sup5.S28

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  8 in total

1.  Modeling manual perineal protection during vaginal delivery.

Authors:  Magdalena Jansova; Vladimir Kalis; Zdenek Rusavy; Robert Zemcik; Libor Lobovsky; Katariina Laine
Journal:  Int Urogynecol J       Date:  2013-07-09       Impact factor: 2.894

Review 2.  The Use of Copper as an Antimicrobial Agent in Health Care, Including Obstetrics and Gynecology.

Authors:  Linda P Arendsen; Ranee Thakar; Abdul H Sultan
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

Review 3.  The Anti-Inflammatory Properties of the Topical Application of Human Milk in Dermal and Optical Diseases.

Authors:  Leila Amiri-Farahani; Zahra Sharifi-Heris; Faraz Mojab
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-23       Impact factor: 2.629

4.  Perineal resuturing versus expectant management following vaginal delivery complicated by a dehisced wound (PREVIEW): a pilot and feasibility randomised controlled trial.

Authors:  L Dudley; C Kettle; P W Thomas; K M K Ismail
Journal:  BMJ Open       Date:  2017-02-10       Impact factor: 2.692

5.  Perineal resuturing versus expectant management following vaginal delivery complicated by a dehisced wound (PREVIEW): a nested qualitative study.

Authors:  L Dudley; C Kettle; J Waterfield; Khaled M K Ismail
Journal:  BMJ Open       Date:  2017-02-10       Impact factor: 2.692

6.  Associations with perineal trauma during childbirth at home and in health facilities in indigenous municipalities in southern Mexico: a cross-sectional cluster survey.

Authors:  Abraham de Jesús-García; Sergio Paredes-Solís; Geovani Valtierra-Gil; Felipe Rene Serrano-de Los Santos; Belén Madeline Sánchez-Gervacio; Robert J Ledogar; Neil Andersson; Anne Cockcroft
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-31       Impact factor: 3.007

7.  Prophylactic antibiotics for the prevention of infection following operative vaginal delivery (ANODE): study protocol for a randomised controlled trial.

Authors:  Marian Knight; Linda Mottram; Shan Gray; Christopher Partlett; Ed Juszczak
Journal:  Trials       Date:  2018-07-24       Impact factor: 2.279

Review 8.  Anti-Inflammatory and Restorative Effects of Olives in Topical Application.

Authors:  Mahdiyeh Taheri; Leila Amiri-Farahani
Journal:  Dermatol Res Pract       Date:  2021-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.